Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2014
11/25/2014US8895254 Biomarkers for ankylosing spondylitis
11/25/2014US8895253 Integrin heterodimer and a subunit thereof
11/25/2014US8895251 Method for detecting human BPLP protein or a maturation product thereof
11/25/2014US8895237 Enhancing of hepatitis B virus vaccine and its gene
11/25/2014US8895030 Interaction of Moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
11/25/2014US8895028 Methods and compositions for dengue virus 3 (DV3) infectious clone
11/25/2014US8895027 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
11/25/2014US8895026 Attenuated pestivirus
11/25/2014US8895025 Infectious cDNA of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/25/2014US8895022 Methods of use of soluble CD24 for therapy of rheumatoid arthritis
11/25/2014US8895021 Sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
11/25/2014US8895020 Single chain trimers and uses therefor
11/25/2014US8895018 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
11/25/2014US8895017 HER-2 peptides and vaccines
11/25/2014US8895016 Antagonists of activin-actriia and uses for increasing red blood cell levels
11/25/2014US8895014 Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
11/25/2014US8895012 sgp130/Fc dimers
11/25/2014US8895006 Ricin ribosome binding protein compositions and methods of use thereof
11/25/2014US8895003 Pharmaceutical composition comprising EDA-1 Fusion Protein
11/25/2014US8895002 Hemojuvelin fusion proteins and uses thereof
11/25/2014US8894999 Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
11/25/2014US8894990 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
11/25/2014US8894861 Method of herding and collection of oil spilled at the aquatic surface
11/20/2014US20140345001 Method for the alteration of plants using cle polypeptides/peptides
11/20/2014US20140344999 Family of pesticidal proteins and methods for their use
11/20/2014US20140344995 Genes for Enhancing Nitrogen Utilization Efficiency in Crop Plants
11/20/2014US20140343254 Tobacco-derived protein compositions
11/20/2014US20140343253 Plasma protein fractionation by sequential polyacid precipitation
11/20/2014US20140343252 Interleukin-2 muteins for the expansion of t-regulatory cells
11/20/2014US20140343250 Recombinant bacteria recognizing protein and uses thereof
11/20/2014US20140343248 Method for enhancing immune response with peptide
11/20/2014US20140342994 Fusion Protein Comprising Circularly Permuted Form Of Trail/Apo2L, Coding Gene And Use Thereof
11/20/2014US20140342993 Kinase inhibitors and uses thereof
11/20/2014US20140342992 Cell-Penetrating Peptides Having a Central Hydrophobic Domain
11/20/2014US20140342990 Maspin-based treatment and prevention of cancer
11/20/2014US20140342982 Gene therapy composition for use in diabetes treatment
11/20/2014US20140342981 Hepatic insulin sensitizing substance and test meal for insulin sensitization
11/20/2014US20140342980 Binding-site modified lectins and uses thereof
11/20/2014US20140342978 Charged Nutritive Proteins and Methods
11/20/2014US20140342930 Methods for selective targeting
11/20/2014US20140342920 Biomarkers for Non-Hodkin Lymphomas and Uses Thereof
11/20/2014US20140342451 Methods of incorporating amino acid analogs into proteins
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/20/2014US20140342400 Solubility enhancing peptide and use thereof
11/20/2014US20140342378 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis
11/20/2014US20140342349 Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the epstein-barr virus (ebv)
11/20/2014US20140341948 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/20/2014US20140341944 Proteins comprising mrsa pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat mrsa infections
11/20/2014US20140341942 Modified Streptococcus Pneumonia Pneumolysin (PLY) Polypeptides
11/20/2014US20140341941 Vaccines and methods for using the same
11/20/2014US20140341939 Modification of helper t cell-inducing polypeptide
11/20/2014US20140341938 Nanoparticle-peptide compositions
11/20/2014US20140341937 Methods and Compositions for Modulating Immune Tolerance
11/20/2014US20140341936 Novel Clostridium Difficile DNA Vaccine
11/20/2014US20140341935 MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE
11/20/2014US20140341931 Soluble cd27 (scd27) and the use thereof
11/20/2014US20140341923 Human Rhinovirus (HRV) Antibodies
11/20/2014US20140341911 Prevention and Treatment of Amyloidogenic Disease
11/20/2014US20140341904 Sparc binding scfvs
11/20/2014US20140341900 Methods of treating cancer
11/20/2014US20140341899 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
11/20/2014US20140341895 PSEUDOMONAS AERUGINOSA OprM EPITOPES FOR USE IN DIAGNOSTICS AND THERAPEUTICS
11/20/2014US20140341892 Anti-alpha2 integrin antibodies and their uses
11/20/2014US20140341876 Method for the treatment of pulmonary disease and method of producing proteins of use therein
11/20/2014US20140341869 Chimeric receptors with 4-1bb stimulatory signaling domain
11/20/2014US20140341858 Neuron generation, regeneration and protection
11/20/2014US20140341852 Capsid-modified raav vector compositions and methods therefor
11/20/2014US20140341843 Purified proteins
11/20/2014US20140341810 Antagonists for abdominal vasopressin v2 receptor and uses thereof
11/18/2014US8889950 Repression of AtGLR3.2 increases plant biomass
11/18/2014US8889850 Inhibitors of heat shock RNA
11/18/2014US8889849 HCV genotype 4 replicons
11/18/2014US8889848 HCV genotype 3 replicons
11/18/2014US8889844 Nucleic acid for treatment or prevention of immunodeficiency virus infection
11/18/2014US8889837 Purification of pegylated polypeptides
11/18/2014US8889833 Antibody to secreted polypeptide
11/18/2014US8889830 Hemoglobin-albumin complex, and artificial plasma expander and artificial oxygen carrier containing the complex
11/18/2014US8889829 Methods of making a diagnostic composition and compositions therefrom
11/18/2014US8889647 Recombinant protein for siRNA delivery and composition comprising the same
11/18/2014US8889641 Modified virus vectors and methods of making and using the same
11/18/2014US8889632 Stabilized p53 peptides and uses thereof
11/18/2014US8889628 Soluble tandem selectin glycoprotein ligand molecules
11/18/2014US8889627 Treatment of multiple sclerosis with combination of laquinimod and fingolimod
11/18/2014US8889626 Triple cross-linked collagen, method of manufacturing the same, and use thereof
11/18/2014US8889623 Immunostimulatory nanoparticles and related compositions, methods and systems
11/18/2014US8889620 Pharmaceutical compositions comprising peptide antagonists of vascular endothelial growth factor
11/18/2014US8889619 Fusion protein of Exendin-4 and its analog, preparation method and use thereof
11/18/2014US8889618 C-terminal fragments of glucagon-like peptide-1 (GLP-1)
11/18/2014US8889616 MUC1 based glycolipopeptide vaccine with adjuvant
11/18/2014US8889615 Methods for promoting epithelialization and healing of chronic wounds
11/18/2014US8889597 Sequences associated with TDP-43 proteinopathies and methods of using the same
11/18/2014US8889426 Methods of identifying inhibitors of FGF23 binding to the binary FGFR-klotho complex for the treatment of hypophosphatemia
11/18/2014US8889425 Means and methods for the determination of camp in vitro and in vivo
11/18/2014US8889419 Methods for enhanced virus-mediated DNA transfer using molecules with virus- and cell-binding domains
11/18/2014US8889408 Factor taking part in transcription control
11/18/2014US8889394 Multiple domain proteins
11/18/2014US8889389 Process for producing protein A-like protein with use of Brevibacillus genus bacterium
11/18/2014US8889377 GPCR comprising an IC2 insertion
11/18/2014US8889376 Fusion protein binding specifically to constant region of antibody, method of preparing the fusion protein, and method of isolating antibody using the fusion protein
11/18/2014US8889374 Recombinant codon optimised factor H
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 2916